On Monday, Neuphoria Therapeutics Inc (NASDAQ: NEUP) opened lower -27.40% from the last session, before settling in for the closing price of $6.24. Price fluctuations for NEUP have ranged from $2.12 to $21.40 over the past 52 weeks.
During the last 5-year period, the sales drop of Healthcare Sector giant was -20.01%. Company’s average yearly earnings per share was noted -1995.65% at the time writing.
Neuphoria Therapeutics Inc (NEUP) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Neuphoria Therapeutics Inc is 4.70%, while institutional ownership is 52.52%. The most recent insider transaction that took place on Oct 21 ’25, was worth 3,283,108. In this transaction 10% Owner of this company bought 639,110 shares at a rate of $5.14, taking the stock ownership to the 875,328 shares.
Neuphoria Therapeutics Inc (NEUP) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1995.65% per share during the next fiscal year.
Neuphoria Therapeutics Inc (NASDAQ: NEUP) Trading Performance Indicators
Check out the current performance indicators for Neuphoria Therapeutics Inc (NEUP). In the past quarter, the stock posted a quick ratio of 11.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.54. Likewise, its price to free cash flow for the trailing twelve months is 18.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -23.89, a number that is poised to hit -1.33 in the next quarter and is forecasted to reach -4.09 in one year’s time.
Technical Analysis of Neuphoria Therapeutics Inc (NEUP)
Looking closely at Neuphoria Therapeutics Inc (NASDAQ: NEUP), its last 5-days average volume was 17.96 million, which is a jump from its year-to-date volume of 0.64 million. As of the previous 9 days, the stock’s Stochastic %D was 8.39%.
During the past 100 days, Neuphoria Therapeutics Inc’s (NEUP) raw stochastic average was set at 4.42%, which indicates a significant decrease from 4.93% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.61 in the past 14 days, which was higher than the 1.01 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.01, while its 200-day Moving Average is $7.40. However, in the short run, Neuphoria Therapeutics Inc’s stock first resistance to watch stands at $5.52. Second resistance stands at $6.50. The third major resistance level sits at $7.00. If the price goes on to break the first support level at $4.04, it is likely to go to the next support level at $3.54. Should the price break the second support level, the third support level stands at $2.56.
Neuphoria Therapeutics Inc (NASDAQ: NEUP) Key Stats
There are currently 2,358K shares outstanding in the company with a market cap of 8.52 million. Presently, the company’s annual sales total 15,650 K according to its annual income of -370 K. Last quarter, the company’s sales amounted to 15,000 K and its income totaled 11,260 K.
